Fair Value Calculator Fair Value Calculator
EN DE

BRADYM (BRADYM) Fair Value & Analysis

IN · Market cap ₹1.7B

B BRADYM BRADYM · BSE
Price₹769.20
Fair Value₹332.43
Upside-56.8%
Quality42/100
Watch BRADYM for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹185.86 – ₹526.51

Fair value as of: Jul 5, 2026

From 24 valuation models · updated today

Share price −5.9% over the past month.

Price vs Fair Value (12 months)

₹2,005 ₹707.15 Fair Value ₹332.43 Jun 2025 Jul 2026

12‑month range ₹707.15 – ₹2,005 · fair‑value band ₹185.86 – ₹526.51 · the ₹769.20 price screens above the ₹332.43 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

BRADYM (BRADYM) currently trades at ₹769.20, while our model-based Fair Value estimate is ₹332.43 — implying the stock looks roughly 56.8% overvalued today. We read business quality at 42/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, BRADYM generated revenue of ₹731M at a net margin of 7.6%. Revenue declined 34.6% year over year. It earns a return on equity of 11.1%. Net debt stands at ₹44.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹185.86 (bear case) to ₹526.51 (bull case); at ₹769.20, the current price sits above that range. The share trades about 62% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹731M
Revenue growth (YoY) -34.6%
Net margin 7.6%
Return on equity 11.1%
Free cash flow ₹18.3M FY2026
P/E ratio 31.0
More key figures
Operating margin 5.2%
EPS (TTM) ₹24.82
EPS growth (YoY) -92.0%
Net debt ₹44.1M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

BRADYM reported revenue of ₹731M in FY2026 versus ₹468M in FY2022, a compound +11.8%/yr. Reported net income was ₹55.7M in FY2026, compounding +14.9%/yr from FY2022.

Revenue +11.8%/yr
FY22 ₹468M
FY23 ₹604M
FY24 ₹752M
FY25 ₹903M
FY26 ₹731M
Net income +14.9%/yr
FY22 ₹31.9M
FY23 ₹50.5M
FY24 ₹84.1M
FY25 ₹240M
FY26 ₹55.7M

Is BRADYM fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "BRADYM Fair Value". https://www.fairvalue-calculator.com/stock/BRADYM

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is BRADYM (BRADYM) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹332.43 versus a price of ₹769.20 — about −57% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BRADYM?
Our model-based fair value for BRADYM is ₹332.43 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹769.20.
What is the quality score of BRADYM?
BRADYM has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of BRADYM (BRADYM)?
BRADYM reported trailing-twelve-month revenue of about ₹731M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of BRADYM?
The net profit margin of BRADYM is about 7.6%, meaning it keeps roughly 7.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.